Data on NASH Candidate ASC40 to be Presented at EASL ILC 2020
HANGZHOU and SHAOXING, China, March 31, 2020 /PRNewswire/ — Ascletis Pharma Inc. (HKEX code: 1672) announces today that its partner Sagimet Biosciences (formerly 3-V Biosciences, Inc), will present clinical and preclinical data on non-alcoholic steatohepatitis (NASH) drug candidate…
Comments Off on Data on NASH Candidate ASC40 to be Presented at EASL ILC 2020